Create an Account | My Bookmarks | Sign in

Home

Pharmaceutical & Life Sciences

Industry: Pharmaceuticals & Life Sciences e-Discovery Services

e-Discovery for Pharmaceutical & Life Sciences Industries

Product liability lawsuits, class action claims, patent disputes and regulatory investigations are constant challenges for pharmaceutical companies. Litigation results in e-discovery requests that dictate sourcing hundreds of custodians, gathering terabytes of data and preparing for multiple and varied venues quickly and efficiently.

Serial litigation and investigation
Product liability and class action claims, intellectual property challenges, and regulatory investigations are daily concerns for pharmaceutical companies. Each legal issue poses its unique challenges. Patent holders must repeatedly defend their IP to ensure revenue streams. Product liability litigation can result in multiple and varied venues, frequently changing schedules, and widely distributed parties and data. Class action creates some of the most complex litigation challenges, with massive data volumes, dozens of outside counsel to manage, and the glare of governmental and public scrutiny.

Drug lifecycle and electronically stored information
Electronic discovery only adds to the litigation and investigation burden. Electronically stored information whether created from drug discovery, clinical trials, sales and marketing programs or during post marketing commitments can be a pharmaceutical company’s litigation downfall or the basis for success in negotiations and at trial.

Addressing pharmaceutical litigation
Fios helps pharmaceutical companies effectively manage litigation activity and regulatory scrutiny with both discovery readiness and discovery response services. Our expert electronic discovery guides tailor a clear, consistent process and technical infrastructure to manage all aspects of e-discovery with deep expertise in meeting pharmaceutical legal teams’ need for compliance, transparency and repeatability. Fios has the capacity and throughput to process enormous volumes of data quickly, putting time on our clients’ side. We also offer active matter consulting in all areas related to e-discovery—from identifying, preserving and collecting data to production, processing and review.

Healthcare and Electronic Discovery
Privacy litigation and governmental investigations (including HIPAA civil enforcement proceedings), disputes regarding payment and reimbursement, medical malpractice lawsuits and other litigation raise significant financial and resource challenges to healthcare providers and health plans. With electronic health records and other electronic data related to treatment, payment and operations increasingly the predominant form of evidence, these disputes invariably result in requests for immense amounts of electronic data, which must be obtained from multiple sources and prepared for disclosure quickly and efficiently. And all this must be done while following strict privacy requirements which govern disclosure of identifiable patient information. Industry Brief: Healthcare and Electronic Discovery >

e-Discovery for Pharmaceutical and Life Sciences companies -- overview

How Fios Can Help

Fios has handled e-discovery for the largest pharmaceutical litigation in U.S. history, and assisted drug companies to efficiently prepare for pending and future litigation. Our e-discovery readiness and response services >

Case Study: Defensibly Processing Complex ESI in Class Actions

A global pharmaceutical company, in the midst of ongoing, class action litigation in both Federal Court and multiple state jurisdictions, was forced to respond to an e-discovery request in one matter involving 1,500 custodians in a four-month timeframe. More than 12 terabytes of electronically stored information (ESI) needed to be collected and reviewed by both the corporation and the supporting law firms.

Read the Case Study >

Recent Pharmaceutical & Life Sciences Case Studies and Other Resources

Case Study: Pharmaceutical Corporation and Intellectual Property Litigation

Although patent litigation is a fact of life for most pharmaceutical companies, few are adequately prepared to manage the costs and risks associated with electronic discovery. When a major domestic drug company faced simultaneous patent challenges against two of its signature products, the company turned to Fios for comprehensive e-discovery response planning to enhance preparations for the pending matters and establish a framework for responding to future litigation more efficiently and cost-ef

Webcast: Proportionality: Why Wait?

It is well-documented that e-discovery consumes increasing percentages of overall civil litigation costs. There is an existing and overlooked approach to reduce electronic discovery costs available now.

Emerging Trends

Whitepaper: Electronic Health Information

Healthcare organizations have been moving in the direction of increased digitization of information for some time, which has picked up considerable speed with monetary grants to expedite the transition to electronic health records in the American Reinvestment and Recovery Act of 2009, also known as the “stimulus package.” Electronic health information will increasingly become the predominant form of evidence in regulatory proceedings and litigation related to healthcare. The potential vulnerabil

e-Discovery Standards & Best Practices

Webcast: Communicate, Collaborate to Lower Risk: Practical Approaches in Pharmaceutical Litigation

It isn't second nature, for litigation-soaked industries like Life Sciences, to collaborate hours after being served. This session will focus on how to use accountabilities, honest communication, and gap analysis to get the most out of your first 120 days when communication is key.

Contact Us

Speak with an e-discovery expert.

1-877-700-3467

Contact Form

More Contact Options

Newsletters

Monthly updates on the latest
e-Discovery industry trends, issues and advances.

View Newsletter

Webcasts

2/28/2012 e-Discovery Case Law Update – Winter/Spring 2012

This quarterly case law update from Fios explores recent court decisions related to e-discovery, the impact these cases may have and are already having, and tactics and strategies organizations should ...